e8vk
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported: August 9, 2006)
AMERUS GROUP CO.
(Exact Name of Registrant as Specified in its Charter)
|
|
|
|
|
IOWA
|
|
001-15166
|
|
42-1458424 |
|
|
|
|
|
(State or Other Jurisdiction
|
|
(Commission File Number)
|
|
(IRS Employer Identification No.) |
of Incorporation) |
|
|
|
|
|
|
|
|
|
699 WALNUT STREET |
|
|
|
|
DES MOINES, IOWA
|
|
|
|
50309-3948 |
|
|
|
|
|
(Address of principal executive offices)
|
|
|
|
(Zip Code) |
Registrants telephone number, including area code: (515) 362-3600
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the
filing obligation of the registrant under any of the following provisions:
o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Item 2.02. Results of Operations and Financial Condition.
On August 9, 2006, Thomas C. Godlasky, Chairman, President and Chief Executive Officer of AmerUs
Group Co. (Company) disclosed the following information during a conference call with Aviva plcs
investors (Teleconference):
|
|
the Companys internal rate of return for traditional life insurance products was
approximately 8% and approximately in excess of 14% for universal and indexed life
products; |
|
|
the Companys internal rate of return for traditional deferred annuities was
approximately 8.5% and approximately in excess of 12.5% for fixed indexed annuities. |
Item 7.01. Regulation FD Disclosure.
During the Teleconference, Mr. Godlasky presented the information attached to this Current Report
on Form 8-K, which the Company is furnishing under this Item 7.01 as Exhibit 99.1. In addition,
Mr. Godlasky stated his belief that the Company could independently fund sales growth at a
compounded annual rate of 20% and that the Company could, as a independent company, increase its
operating return on equity to over 14% during the next three to five years. This projection is
based on adjusted net operating income which is a non-GAAP financial measure. Due to the
unpredictability of the timing and recognition of gains and losses (especially credit impairments),
trading gains and losses, FAS 133 adjustments as well as the unpredictable nature of certain other
items that management believes are not indicative of ongoing operational performance, GAAP net
income cannot readily be estimated because management has not regularly projected the foregoing
items. Since GAAP net income cannot be readily estimated, the Company is unable to provide
guidance with respect to, or a reconciliation of guidance on operating return on equity to, GAAP
return on equity.
This Current Report on Form 8-K contains statements which constitute forward-looking statements
within the meaning of the Private Securities Litigation Reform Act of 1995, including statements
relating to trends in our operations and financial results and our business and products, which
include words such as anticipate, believe, plan, estimate, expect, intend, and other
similar expressions. Forward-looking statements are made based upon managements current
expectations and beliefs concerning future developments and their potential effects on the Company.
Such forward-looking statements are not guarantees of future performance. Factors that may cause
our actual results to differ materially from those contemplated by these forward-looking statements
include, among others, the following possibilities: (a) our shareholders may not approve and adopt
the merger agreement with Aviva plc and the transactions contemplated by the merger agreement at
the special shareholder meeting; (b) the parties may be unable to obtain governmental and
regulatory approvals required for such merger, or required governmental and regulatory approvals
may delay the merger or result in the imposition of conditions that could cause the parties to
abandon the merger; (c) the parties may be unable to complete the merger because, among other
reasons, conditions to the closing of the merger may not be satisfied or waived; (d) general
economic conditions and other factors, including prevailing interest rate levels and stock and bond
market performance, which may affect (1) our ability to sell our products, (2) the market value of
our investments and consequently protection product and accumulation product margins and (3) the
lapse rate and profitability of policies; (e) the performance of our investment portfolios which
may be affected by general economic conditions, the continued credit quality of the companies whose
securities
we invest in and the impact of other investment transactions; (f) customer response to
new products, distribution channels and marketing initiatives and increasing competition in the
sale of insurance and annuities and the recruitment of sales representatives from companies that
may have greater financial resources, broader arrays of products, higher ratings and stronger
financial performance may impair our ability to retain existing customers, attract new customers
and maintain our profitability; (g) our ratings and those of our subsidiaries by independent rating
organizations which we believe are particularly important to the sale of our products; (h)
mortality, morbidity, and other factors which may affect the profitability of our insurance
products; (i) our ability to develop and maintain effective risk management policies and procedures
and to maintain adequate reserves for future policy benefits and claims; (j) litigation or
regulatory investigations or examinations; (k) regulatory changes, interpretations, initiatives or
pronouncements, including those relating to the regulation of insurance companies and the
regulation and sales of their products and the programs in which they are used; (l) changes in the
federal income tax and other federal laws, regulations, and interpretations, including federal
regulatory measures that may significantly affect the insurance business including limitations on
antitrust immunity, the applicability of securities laws to insurance products, minimum solvency
requirements, and changes to the tax advantages offered by life insurance and annuity products or
programs with which they are used; (m) the impact of changes in standards of accounting; (n) our
ability to achieve anticipated levels of operational efficiencies and cost-saving initiatives and
to meet cash requirements based upon projected liquidity sources; (o) our ability to integrate the
business and operations of acquired entities; and (p) various other factors discussed in Item 1A.
Risk Factors of our Annual Report on Form 10-K for the period ended December 31, 2005 and of our
Quarterly Report on Form 10-Q for the Period ended on June 30, 2006.
There can be no assurance that other factors not currently anticipated by us will not materially
and adversely affect our results of operations. You are cautioned not to place undue reliance on
any forward-looking statements made by us or on our behalf. Forward-looking statements speak only
as of the date the statement was made. We undertake no obligation to update or revise any
forward-looking statement.
Item 9.01 (d). Exhibits
99.1 Presentation dated August 9, 2006 (furnished pursuant to Item 7.01).
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the Registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
|
|
|
|
|
|
AMERUS GROUP CO.
|
|
|
By: |
/s/ Christopher J. Littlefield
|
|
|
|
Christopher J. Littlefield |
|
|
|
Executive Vice President
& General Counsel |
|
|
Dated: August 9, 2006
EXHIBITS
|
|
|
Exhibit No. |
|
Description |
|
|
|
|
|
|
99.1
|
|
Presentation dated August 9, 2006 (furnished pursuant to Item 7.01). |